StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NRC

NRC Health

NRC Nasdaq Services-Commercial Physical & Biological Research EDGAR ↗
$19.50
+0.59 +3.12%

Key statistics

from XBRL data in SEC filings
Market cap
$439M
Revenue (TTM)
$139M
Net income (TTM)
$9.04M
EPS (TTM)
$49.89
P/E ratio
0.4
Dividend yield
2.87%
Free cash flow
$15.7M
Cash
$2.55M
Total assets
$135M
Gross margin
52-week range
$11.01 – $23.68

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release) Jul 28, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 29, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 28, 2026 8-K Director or officer change Apr 28, 2026 8-K Results of operations (earnings release) Apr 28, 2026 8-K Director or officer change; Amended charter or bylaws Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Regulation FD disclosure Mar 5, 2026 8-K Results of operations (earnings release) Feb 3, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Oct 27, 2025 8-K Director or officer change Aug 28, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Jul 28, 2025 8-K Director or officer change; Shareholder vote results May 12, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 28, 2025 8-K Director or officer change Apr 22, 2025 8-K Director or officer change Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Director or officer change Mar 4, 2025 8-K Entered a material agreement; Took on a direct financial obligation Feb 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 27, 2025 8-K Director or officer change Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Oct 25, 2024 8-K Director or officer change Oct 15, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Entered a material agreement; Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results May 13, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Director or officer change May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release); Director or officer change Feb 13, 2024 8-K Director or officer change; Regulation FD disclosure Jan 17, 2024 8-K Director or officer change Jan 2, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 8, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023